Sedana Medical AB (publ) (FRA:7D2A)

Sedana Medical AB Statistics

Total Valuation

FRA:7D2A has a market cap or net worth of EUR 88.05 million. The enterprise value is 78.22 million.

Market Cap	88.05M
Enterprise Value	78.22M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	99.34M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.03%
Owned by Institutions (%)	39.70%
Float	65.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.93
PB Ratio	1.07
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.28
EV / Sales	4.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-380.46

Financial Position

The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.00.

Current Ratio	4.16
Quick Ratio	3.08
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-1.78
Interest Coverage	-11.28

Financial Efficiency

Return on equity (ROE) is -4.37% and return on invested capital (ROIC) is -2.40%.

Return on Equity (ROE)	-4.37%
Return on Assets (ROA)	-2.29%
Return on Invested Capital (ROIC)	-2.40%
Return on Capital Employed (ROCE)	-3.91%
Revenue Per Employee	152,768
Profits Per Employee	-31,424
Employee Count	109
Asset Turnover	0.20
Inventory Turnover	1.46

Taxes

In the past 12 months, FRA:7D2A has paid 184,339 in taxes.

Income Tax	184,339
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.63%
50-Day Moving Average	0.98
200-Day Moving Average	1.09
Relative Strength Index (RSI)	45.20
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:7D2A had revenue of EUR 17.87 million and -3.68 million in losses. Loss per share was -0.04.

Revenue	17.87M
Gross Profit	12.60M
Operating Income	-3.25M
Pretax Income	-3.49M
Net Income	-3.68M
EBITDA	-3.08M
EBIT	-3.25M
Loss Per Share	-0.04

Balance Sheet

The company has 10.13 million in cash and 366,869 in debt, giving a net cash position of 9.76 million.

Cash & Cash Equivalents	10.13M
Total Debt	366,869
Net Cash	9.76M
Net Cash Per Share	n/a
Equity (Book Value)	82.17M
Book Value Per Share	0.83
Working Capital	13.30M

Cash Flow

In the last 12 months, operating cash flow was -22,703 and capital expenditures -182,892, giving a free cash flow of -205,595.

Operating Cash Flow	-22,703
Capital Expenditures	-182,892
Free Cash Flow	-205,595
FCF Per Share	n/a

Margins

Gross margin is 70.47%, with operating and profit margins of -18.18% and -20.57%.

Gross Margin	70.47%
Operating Margin	-18.18%
Pretax Margin	-19.54%
Profit Margin	-20.57%
EBITDA Margin	-17.24%
EBIT Margin	-18.18%
FCF Margin	n/a

Dividends & Yields

FRA:7D2A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.18%
FCF Yield	-0.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 26, 2021. It was a forward split with a ratio of 4.

Last Split Date	May 26, 2021
Split Type	Forward
Split Ratio	4

Scores

FRA:7D2A has an Altman Z-Score of 14.72 and a Piotroski F-Score of 2.

Altman Z-Score	14.72
Piotroski F-Score	2